These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Efficacy of Microsurgical Sublabial Approach (MSA) Versus Endoscopic Endonasal Approach (EEA) for the Treatment of Pituitary Adenomas Based on Radiological and Hormonal Outcome. Mattogno PP; Mangiola A; Lofrese G; Vigo V; Anile C Acta Neurochir Suppl; 2017; 124():101-106. PubMed ID: 28120060 [TBL] [Abstract][Full Text] [Related]
43. Outcomes after a purely endoscopic transsphenoidal resection of growth hormone-secreting pituitary adenomas. Campbell PG; Kenning E; Andrews DW; Yadla S; Rosen M; Evans JJ Neurosurg Focus; 2010 Oct; 29(4):E5. PubMed ID: 20887130 [TBL] [Abstract][Full Text] [Related]
44. Extended transsphenoidal approach for pituitary adenomas invading the anterior cranial base, cavernous sinus, and clivus: a single-center experience with 126 consecutive cases. Zhao B; Wei YK; Li GL; Li YN; Yao Y; Kang J; Ma WB; Yang Y; Wang RZ J Neurosurg; 2010 Jan; 112(1):108-17. PubMed ID: 19408986 [TBL] [Abstract][Full Text] [Related]
45. Utility and safety of the flexible-fiber CO2 laser in endoscopic endonasal transsphenoidal surgery. Jayarao M; Devaiah AK; Chin LS World Neurosurg; 2011; 76(1-2):149-55. PubMed ID: 21839966 [TBL] [Abstract][Full Text] [Related]
46. One-and-a-half nostril endoscopic transsphenoidal approach for pituitary adenomas-a technical report. Wen G; Tang C; Zhong C; Li J; Cong Z; Zhou Y; Liu K; Zhang Y; Tohti M; Ma C J Otolaryngol Head Neck Surg; 2016 Nov; 45(1):60. PubMed ID: 27846864 [TBL] [Abstract][Full Text] [Related]
47. Microscopic endonasal transsphenoidal pituitary adenomectomy in the pediatric population. Tarapore PE; Sughrue ME; Blevins L; Auguste KI; Gupta N; Kunwar S J Neurosurg Pediatr; 2011 May; 7(5):501-9. PubMed ID: 21529190 [TBL] [Abstract][Full Text] [Related]
49. Safety and Effectiveness of the Direct Endoscopic Endonasal Approach for Primary Sellar Pathology: A Contemporary Case Series of More Than 400 Patients. Cardinal T; Brunswick A; Strickland BA; Micko A; Shiroishi M; Liu CJ; Wrobel B; Carmichael JD; Zada G World Neurosurg; 2021 Apr; 148():e536-e546. PubMed ID: 33454431 [TBL] [Abstract][Full Text] [Related]
50. [Analysis of outcomes and learning curve of endoscopic transsphenoidal surgeries for 124 patients with pituitary adenomas]. Zhang LY; Deng K; Zhang Y; Feng M; Bao XJ; Liu XH; Xing B; Lian W; Wang RZ; Yao Y Zhonghua Yi Xue Za Zhi; 2016 May; 96(19):1485-8. PubMed ID: 27266492 [TBL] [Abstract][Full Text] [Related]
51. Hemorrhagic pituitary macroadenoma: characteristics, endoscopic endonasal transsphenoidal surgery, and outcomes. Zhang X; Zhang W; Fu LA; Cheng JX; Liu BL; Cao WD; Fei Z; Zhang JN; Liu WP; Zhen HN Ann Surg Oncol; 2011 Jan; 18(1):246-52. PubMed ID: 20703818 [TBL] [Abstract][Full Text] [Related]
52. A follow-up study on outcomes of endoscopic transsphenoidal approach for acromegaly. Aydin S; Ozoner B; Sahin S; Alizada O; Comunoglu N; Oz B; Gazioglu N; Kadioglu P; Tanriover N Clin Neurol Neurosurg; 2020 Nov; 198():106201. PubMed ID: 32927330 [TBL] [Abstract][Full Text] [Related]
53. The endoscopic endonasal approach for recurrent pituitary lesions. Laws ER World Neurosurg; 2013; 80(3-4):272-3. PubMed ID: 23165173 [No Abstract] [Full Text] [Related]
54. Complications after transsphenoidal surgery for patients with Cushing's disease and silent corticotroph adenomas. Smith TR; Hulou MM; Huang KT; Nery B; de Moura SM; Cote DJ; Laws ER Neurosurg Focus; 2015 Feb; 38(2):E12. PubMed ID: 25639314 [TBL] [Abstract][Full Text] [Related]
55. Atypical pituitary adenomas: clinical characteristics and role of ki-67 and p53 in prognostic and therapeutic evaluation. A series of 50 patients. Del Basso De Caro M; Solari D; Pagliuca F; Villa A; Guadagno E; Cavallo LM; Colao A; Pettinato G; Cappabianca P Neurosurg Rev; 2017 Jan; 40(1):105-114. PubMed ID: 27215912 [TBL] [Abstract][Full Text] [Related]
56. The Endoscopic Endonasal Transsphenoidal Approach for Thyrotropin-Secreting Pituitary Adenomas: Single-Center Experience and Clinical Outcomes of 49 Patients. Sen HE; Ceylan EC; Atayev S; Sozen M; Bayrak BY; Cetinarslan B; Anik Y; Icli AD; Cabuk B; Anik I; Ceylan S World Neurosurg; 2022 Nov; 167():e1275-e1283. PubMed ID: 36096394 [TBL] [Abstract][Full Text] [Related]
57. Evidence of improved surgical outcome following endoscopy for nonfunctioning pituitary adenoma removal. Messerer M; De Battista JC; Raverot G; Kassis S; Dubourg J; Lapras V; Trouillas J; Perrin G; Jouanneau E Neurosurg Focus; 2011 Apr; 30(4):E11. PubMed ID: 21456922 [TBL] [Abstract][Full Text] [Related]
58. Surgical complications associated with the endoscopic endonasal transsphenoidal approach for pituitary adenomas. Cappabianca P; Cavallo LM; Colao A; de Divitiis E J Neurosurg; 2002 Aug; 97(2):293-8. PubMed ID: 12186456 [TBL] [Abstract][Full Text] [Related]
59. Prospective comparison of sinonasal outcomes after microscopic sublabial or endoscopic endonasal transsphenoidal surgery for nonfunctioning pituitary adenomas. Pledger CL; Elzoghby MA; Oldfield EH; Payne SC; Jane JA J Neurosurg; 2016 Aug; 125(2):323-33. PubMed ID: 26654174 [TBL] [Abstract][Full Text] [Related]
60. Endoscopic Endonasal Approach Combined with a Simultaneous Transcranial Approach for Giant Pituitary Tumors. Kuga D; Toda M; Ozawa H; Ogawa K; Yoshida K World Neurosurg; 2019 Jan; 121():173-179. PubMed ID: 30336293 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]